Quantcast

Latest FDA Stories

2015-03-04 23:05:39

Sports Nutrition Ingredient, Nitrosigine, Supplies Bodybuilding Expo with Bicep Pump Challenge Columbus, Ohio (PRWEB) March 04, 2015 Nitrosigine®,

2015-03-04 23:01:57

The FDA is requiring the manufacturers of low testosterone therapy drugs to warn patients that the medications may increase the risk for heart attacks and strokes. New

2015-03-04 23:01:04

FDA investigators generally know within four hours of an inspection whether a manufacturer’s in trouble or not.

2015-03-04 23:00:57

NuMale Medical Center Founder and Chief Medical Officer Dr. Christopher Asandra, M.D.

2015-03-03 20:22:12

- Initial Hepatoren® Phase II study results NASHVILLE, Tenn., March 3, 2015 /PRNewswire/ -- Cumberland Pharmaceuticals Inc.

2015-03-03 12:28:52

HORSHOLM, Denmark, March 3, 2015 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) ('Veloxis') today published the annual report of Veloxis Pharmaceuticals A/S for the financial year 2014.

2015-03-02 23:08:54

FDA one step closer to final approval for sight saving treatment that could help hundreds of thousands across U.S. San Antonio eye surgeon Dr.

2015-03-02 23:08:35

The San Diego based law firm with its national network of experienced lawyers comments on the FDA's Adverse Reaction changes to the anticoagulant's labeling, as well as the development

2015-03-02 23:01:57

The decision by UnitedHealthCare to restrict laparoscopic or abdominal hysterectomies comes months after the FDA warned against the use of power morcellators in such procedures, as the devices

2015-03-02 12:31:48

DALLAS, March 2, 2015 /PRNewswire/ -- ReportsnReports.com adds Lonsurf and Avastin (Colorectal Cancer) - Forecast and Market Analysis to 2023 research report focuses on


Word of the Day
quilisma
  • In medieval musical notation, a sign or neume denoting a shake or trill.
The word 'quilisma' comes from a Greek word meaning 'a roll'.